Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Pulmonary vascular imaging characteristics after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.

Braams NJ, Ruigrok D, Schokker MGM, Padervinskiene L, de Man FS, Marcus JT, Lely RJ, Beijk MAM, Klok FA, Huisman MV, Nossent EJ, Vonk Noordegraaf A, Symersky P, Bogaard HJ, Meijboom LJ.

J Heart Lung Transplant. 2020 Mar;39(3):248-256. doi: 10.1016/j.healun.2019.11.020. Epub 2019 Dec 5.

PMID:
31866175
2.

Effects of 6-mercaptopurine in pressure overload induced right heart failure.

Axelsen JB, Andersen S, Sun XQ, Ringgaard S, Hyldebrandt JA, Kurakula K, Goumans MJ, de Man FS, Nielsen-Kudsk JE, Bogaard HJ, Andersen A.

PLoS One. 2019 Nov 12;14(11):e0225122. doi: 10.1371/journal.pone.0225122. eCollection 2019.

3.

Hemodynamic Effects of Pulmonary Arterial Hypertension-Specific Therapy in Patients With Heart Failure With Preserved Ejection Fraction and With Combined Post- and Precapillay Pulmonary Hypertension.

Huis In't Veld AE, Oosterveer FPT, De Man FS, Marcus JT, Nossent EJ, Boonstra A, Van Rossum ACB, Vonk Noordegraaf A, Bogaard HJ, Handoko ML.

J Card Fail. 2020 Jan;26(1):26-34. doi: 10.1016/j.cardfail.2019.07.547. Epub 2019 Aug 5.

PMID:
31394199
4.

The right treatment for the right ventricle.

Groeneveldt JA, de Man FS, Westerhof BE.

Curr Opin Pulm Med. 2019 Sep;25(5):410-417. doi: 10.1097/MCP.0000000000000610.

5.

Vena cava backflow and right ventricular stiffness in pulmonary arterial hypertension.

Marcus JT, Westerhof BE, Groeneveldt JA, Bogaard HJ, de Man FS, Vonk Noordegraaf A.

Eur Respir J. 2019 Oct 17;54(4). pii: 1900625. doi: 10.1183/13993003.00625-2019. Print 2019 Oct.

PMID:
31320456
6.

The right treatment for the right ventricle.

Groeneveldt JA, de Man FS, Westerhof BE.

Curr Opin Pulm Med. 2019 Jul 22. doi: 10.1097/MCP.0000000000000610. [Epub ahead of print]

PMID:
31313743
7.

Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in experimental pulmonary hypertension and right ventricular failure.

Andersen S, Axelsen JB, Ringgaard S, Nyengaard JR, Hyldebrandt JA, Bogaard HJ, de Man FS, Nielsen-Kudsk JE, Andersen A.

Int J Cardiol. 2019 Oct 15;293:203-210. doi: 10.1016/j.ijcard.2019.06.065. Epub 2019 Jun 29.

PMID:
31307846
8.

Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling.

Kurakula K, Sun XQ, Happé C, da Silva Goncalves Bos D, Szulcek R, Schalij I, Wiesmeijer KC, Lodder K, Tu L, Guignabert C, de Vries CJM, de Man FS, Vonk Noordegraaf A, Ten Dijke P, Goumans MJ, Bogaard HJ.

Eur Respir J. 2019 Sep 29;54(3). pii: 1802400. doi: 10.1183/13993003.02400-2018. Print 2019 Sep.

PMID:
31273046
9.

Pressure overload induced right ventricular remodeling is not attenuated by the anti-fibrotic agent pirfenidone.

Andersen S, Birkmose Axelsen J, Ringgaard S, Randel Nyengaard J, Holm Nielsen S, Genovese F, Asser Karsdal M, Adler Hyldebrandt J, Brandt Sørensen C, de Man FS, Jan Bogaard H, Erik Nielsen-Kudsk J, Andersen A.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019848659. doi: 10.1177/2045894019848659.

10.

The unknown pathophysiological relevance of right ventricular hypertrophy in pulmonary arterial hypertension.

de Man FS, Handoko ML, Vonk-Noordegraaf A.

Eur Respir J. 2019 Apr 4;53(4). pii: 1900255. doi: 10.1183/13993003.00255-2019. Print 2019 Apr. No abstract available.

PMID:
30948507
11.

Right Ventricular Fibrosis.

Andersen S, Nielsen-Kudsk JE, Vonk Noordegraaf A, de Man FS.

Circulation. 2019 Jan 8;139(2):269-285. doi: 10.1161/CIRCULATIONAHA.118.035326.

PMID:
30615500
12.

3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.

Ashek A, Spruijt OA, Harms HJ, Lammertsma AA, Cupitt J, Dubois O, Wharton J, Dabral S, Pullamsetti SS, Huisman MC, Frings V, Boellaard R, de Man FS, Botros L, Jansen S, Vonk Noordegraaf A, Wilkins MR, Bogaard HJ, Zhao L.

Circ Cardiovasc Imaging. 2018 Aug;11(8):e007402. doi: 10.1161/CIRCIMAGING.117.007402.

13.

Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.

Rol N, de Raaf MA, Sun XQ, Kuiper VP, da Silva Gonçalves Bos D, Happé C, Kurakula K, Dickhoff C, Thuillet R, Tu L, Guignabert C, Schalij I, Lodder K, Pan X, Herrmann FE, van Nieuw Amerongen GP, Koolwijk P, Vonk-Noordegraaf A, de Man FS, Wollin L, Goumans MJ, Szulcek R, Bogaard HJ.

Cardiovasc Res. 2019 Feb 1;115(2):432-439. doi: 10.1093/cvr/cvy186.

PMID:
30032282
14.

Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.

da Silva Gonçalves Bós D, Van Der Bruggen CEE, Kurakula K, Sun XQ, Casali KR, Casali AG, Rol N, Szulcek R, Dos Remedios C, Guignabert C, Tu L, Dorfmüller P, Humbert M, Wijnker PJM, Kuster DWD, van der Velden J, Goumans MJ, Bogaard HJ, Vonk-Noordegraaf A, de Man FS, Handoko ML.

Circulation. 2018 Feb 27;137(9):910-924. doi: 10.1161/CIRCULATIONAHA.117.027451. Epub 2017 Nov 22.

PMID:
29167228
15.

Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension.

da Silva Gonçalves Bos D, Happé C, Schalij I, Pijacka W, Paton JFR, Guignabert C, Tu L, Thuillet R, Bogaard HJ, van Rossum AC, Vonk-Noordegraaf A, de Man FS, Handoko ML.

JACC Basic Transl Sci. 2017 Feb 1;2(1):22-35. doi: 10.1016/j.jacbts.2016.09.007. eCollection 2017 Feb.

16.

A focus on the greatness of the lesser circulation: spotlight issue on the right ventricle.

de Man FS, La Gerche A.

Cardiovasc Res. 2017 Oct 1;113(12):1421-1422. doi: 10.1093/cvr/cvx168. No abstract available.

PMID:
28957539
17.

RV pressure overload: from hypertrophy to failure.

van der Bruggen CEE, Tedford RJ, Handoko ML, van der Velden J, de Man FS.

Cardiovasc Res. 2017 Oct 1;113(12):1423-1432. doi: 10.1093/cvr/cvx145. Review.

PMID:
28957530
18.

Vascular remodelling in the pulmonary circulation after major lung resection.

Rol N, Happé C, Beliën JAM, de Man FS, Westerhof N, Vonk-Noordegraaf A, Grünberg K, Bogaard HJ.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700806. doi: 10.1183/13993003.00806-2017. Print 2017 Aug. No abstract available.

19.

Treatment response in patients with idiopathic pulmonary arterial hypertension and a severely reduced diffusion capacity.

van der Bruggen CE, Spruijt OA, Nossent EJ, Trip P, Marcus JT, de Man FS, Jan Bogaard H, Noordegraaf AV.

Pulm Circ. 2017 Mar 13;7(1):137-144. doi: 10.1086/690016. eCollection 2017 Mar.

20.

Use of β-Blockers in Pulmonary Hypertension.

Perros F, de Man FS, Bogaard HJ, Antigny F, Simonneau G, Bonnet S, Provencher S, Galiè N, Humbert M.

Circ Heart Fail. 2017 Apr;10(4). pii: e003703. doi: 10.1161/CIRCHEARTFAILURE.116.003703. Review.

PMID:
28364092
21.

The effect of perioperative insulin treatment on cardiodepression in mild adiposity in mice.

Boly CA, Eringa EC, Bouwman RA, van den Akker RF, de Man FS, Schalij I, Loer SA, Boer C, van den Brom CE.

Cardiovasc Diabetol. 2016 Sep 20;15(1):135. doi: 10.1186/s12933-016-0453-y.

22.

A critical appraisal of transpulmonary and diastolic pressure gradients.

Handoko ML, De Man FS, Oosterveer FP, Bogaard HJ, Vonk-Noordegraaf A, Westerhof N.

Physiol Rep. 2016 Sep;4(17). pii: e12910. doi: 10.14814/phy2.12910.

23.

Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".

van der Bruggen CE, Happé CM, Goumans MJ, Bogaard HJ, Vonk Noordegraaf A, de Man FS.

Circulation. 2016 Aug 30;134(9):e117-8. doi: 10.1161/CIRCULATIONAHA.116.024173. No abstract available.

PMID:
27572883
24.

Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study.

van Campen JS, de Boer K, van de Veerdonk MC, van der Bruggen CE, Allaart CP, Raijmakers PG, Heymans MW, Marcus JT, Harms HJ, Handoko ML, de Man FS, Vonk Noordegraaf A, Bogaard HJ.

Eur Respir J. 2016 Sep;48(3):787-96. doi: 10.1183/13993003.00090-2016. Epub 2016 Jul 7.

25.

Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension: Relative Contribution of Fibrosis and Myofibril Stiffness.

Rain S, Andersen S, Najafi A, Gammelgaard Schultz J, da Silva Gonçalves Bós D, Handoko ML, Bogaard HJ, Vonk-Noordegraaf A, Andersen A, van der Velden J, Ottenheijm CA, de Man FS.

Circ Heart Fail. 2016 Jul;9(7). pii: e002636. doi: 10.1161/CIRCHEARTFAILURE.115.002636.

26.

Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.

de Raaf MA, Herrmann FE, Schalij I, de Man FS, Vonk-Noordegraaf A, Guignabert C, Wollin L, Bogaard HJ.

Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H604-12. doi: 10.1152/ajpheart.00656.2015. Epub 2016 Jun 24.

27.

Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertension.

Manders E, Bonta PI, Kloek JJ, Symersky P, Bogaard HJ, Hooijman PE, Jasper JR, Malik FI, Stienen GJ, Vonk-Noordegraaf A, de Man FS, Ottenheijm CA.

Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L20-8. doi: 10.1152/ajplung.00113.2016. Epub 2016 May 17.

28.

Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.

Happé CM, de Raaf MA, Rol N, Schalij I, Vonk-Noordegraaf A, Westerhof N, Voelkel NF, de Man FS, Bogaard HJ.

Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1088-97. doi: 10.1152/ajplung.00023.2016. Epub 2016 Apr 1.

29.

Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.

van der Bruggen CE, Happé CM, Dorfmüller P, Trip P, Spruijt OA, Rol N, Hoevenaars FP, Houweling AC, Girerd B, Marcus JT, Mercier O, Humbert M, Handoko ML, van der Velden J, Vonk Noordegraaf A, Bogaard HJ, Goumans MJ, de Man FS.

Circulation. 2016 May 3;133(18):1747-60. doi: 10.1161/CIRCULATIONAHA.115.020696. Epub 2016 Mar 16.

PMID:
26984938
30.

How to diagnose heart failure with preserved ejection fraction: the value of invasive stress testing.

Huis In 't Veld AE, de Man FS, van Rossum AC, Handoko ML.

Neth Heart J. 2016 Apr;24(4):244-51. doi: 10.1007/s12471-016-0811-0. Review.

31.

Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.

Szulcek R, Happé CM, Rol N, Fontijn RD, Dickhoff C, Hartemink KJ, Grünberg K, Tu L, Timens W, Nossent GD, Paul MA, Leyen TA, Horrevoets AJ, de Man FS, Guignabert C, Yu PB, Vonk-Noordegraaf A, van Nieuw Amerongen GP, Bogaard HJ.

Am J Respir Crit Care Med. 2016 Jun 15;193(12):1410-20. doi: 10.1164/rccm.201506-1231OC.

32.

Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency.

Ruiter G, Manders E, Happé CM, Schalij I, Groepenhoff H, Howard LS, Wilkins MR, Bogaard HJ, Westerhof N, van der Laarse WJ, de Man FS, Vonk-Noordegraaf A.

Pulm Circ. 2015 Sep;5(3):466-72. doi: 10.1086/682217.

33.

Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model.

de Raaf MA, Kroeze Y, Middelman A, de Man FS, de Jong H, Vonk-Noordegraaf A, de Korte C, Voelkel NF, Homberg J, Bogaard HJ.

Am J Physiol Lung Cell Mol Physiol. 2015 Nov 15;309(10):L1164-73. doi: 10.1152/ajplung.00127.2015. Epub 2015 Sep 18.

34.

β-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure.

de Man FS, Handoko ML.

Eur Respir J. 2015 Sep;46(3):619-21. doi: 10.1183/09031936.00051215. No abstract available.

35.

The striated muscles in pulmonary arterial hypertension: adaptations beyond the right ventricle.

Manders E, Rain S, Bogaard HJ, Handoko ML, Stienen GJ, Vonk-Noordegraaf A, Ottenheijm CA, de Man FS.

Eur Respir J. 2015 Sep;46(3):832-42. doi: 10.1183/13993003.02052-2014. Epub 2015 Jun 25. Review.

36.

Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension.

Trip P, Rain S, Handoko ML, van der Bruggen C, Bogaard HJ, Marcus JT, Boonstra A, Westerhof N, Vonk-Noordegraaf A, de Man FS.

Eur Respir J. 2015 Jun;45(6):1603-12. doi: 10.1183/09031936.00156714. Epub 2015 Apr 16.

37.

Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension.

Manders E, Ruiter G, Bogaard HJ, Stienen GJ, Vonk-Noordegraaf A, de Man FS, Ottenheijm CA.

Eur Respir J. 2015 Jun;45(6):1737-40. doi: 10.1183/09031936.00205114. Epub 2015 Mar 5. No abstract available.

38.

The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension.

Spruijt OA, de Man FS, Groepenhoff H, Oosterveer F, Westerhof N, Vonk-Noordegraaf A, Bogaard HJ.

Am J Respir Crit Care Med. 2015 May 1;191(9):1050-7. doi: 10.1164/rccm.201412-2271OC.

PMID:
25710636
39.

Sympathetic nervous system activation and β-adrenoceptor blockade in right heart failure.

Andersen S, Andersen A, de Man FS, Nielsen-Kudsk JE.

Eur J Heart Fail. 2015 Apr;17(4):358-66. doi: 10.1002/ejhf.253. Epub 2015 Feb 22. Review.

40.

Predicting pulmonary hypertension with standard computed tomography pulmonary angiography.

Spruijt OA, Bogaard HJ, Heijmans MW, Lely RJ, van de Veerdonk MC, de Man FS, Westerhof N, Vonk-Noordegraaf A.

Int J Cardiovasc Imaging. 2015 Apr;31(4):871-9. doi: 10.1007/s10554-015-0618-x. Epub 2015 Feb 17.

41.

Risk-stratification in normotensive acute pulmonary embolism.

Handoko ML, de Man FS.

Neth Heart J. 2015 Jan;23(1):52-4. doi: 10.1007/s12471-014-0639-4. No abstract available.

42.

Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension.

van de Veerdonk MC, Marcus JT, Westerhof N, de Man FS, Boonstra A, Heymans MW, Bogaard HJ, Vonk Noordegraaf A.

Chest. 2015 Apr;147(4):1063-1071. doi: 10.1378/chest.14-0701.

PMID:
25376008
43.

Effects of bisoprolol and losartan treatment in the hypertrophic and failing right heart.

Andersen S, Schultz JG, Andersen A, Ringgaard S, Nielsen JM, Holmboe S, Vildbrad MD, de Man FS, Bogaard HJ, Vonk-Noordegraaf A, Nielsen-Kudsk JE.

J Card Fail. 2014 Nov;20(11):864-73. doi: 10.1016/j.cardfail.2014.08.003. Epub 2014 Aug 15.

PMID:
25135110
44.

Contractile dysfunction of left ventricular cardiomyocytes in patients with pulmonary arterial hypertension.

Manders E, Bogaard HJ, Handoko ML, van de Veerdonk MC, Keogh A, Westerhof N, Stienen GJ, Dos Remedios CG, Humbert M, Dorfmüller P, Fadel E, Guignabert C, van der Velden J, Vonk-Noordegraaf A, de Man FS, Ottenheijm CA.

J Am Coll Cardiol. 2014 Jul 8;64(1):28-37. doi: 10.1016/j.jacc.2014.04.031.

45.

Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension.

Rain S, Bos Dda S, Handoko ML, Westerhof N, Stienen G, Ottenheijm C, Goebel M, Dorfmüller P, Guignabert C, Humbert M, Bogaard HJ, Remedios CD, Saripalli C, Hidalgo CG, Granzier HL, Vonk-Noordegraaf A, van der Velden J, de Man FS.

J Am Heart Assoc. 2014 Jun 3;3(3):e000716. doi: 10.1161/JAHA.113.000716.

46.

SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.

de Raaf MA, Schalij I, Gomez-Arroyo J, Rol N, Happé C, de Man FS, Vonk-Noordegraaf A, Westerhof N, Voelkel NF, Bogaard HJ.

Eur Respir J. 2014 Jul;44(1):160-8. doi: 10.1183/09031936.00204813. Epub 2014 May 2.

47.

The interventricular septum in pulmonary hypertension does not show features of right ventricular failure.

Ruiter G, van de Veerdonk MC, Bogaard HJ, Wong YY, Marcus JT, Lammertsma AA, Westerhof N, van der Laarse WJ, de Man FS, Vonk-Noordegraaf A.

Int J Cardiol. 2014 May 15;173(3):509-12. doi: 10.1016/j.ijcard.2014.03.064. Epub 2014 Mar 18. No abstract available.

PMID:
24684998
48.

Diaphragm fiber strength is reduced in critically ill patients and restored by a troponin activator.

Hooijman PE, Beishuizen A, de Waard MC, de Man FS, Vermeijden JW, Steenvoorde P, Bouwman RA, Lommen W, van Hees HW, Heunks LM, Dickhoff C, van der Peet DL, Girbes AR, Jasper JR, Malik FI, Stienen GJ, Hartemink KJ, Paul MA, Ottenheijm CA.

Am J Respir Crit Care Med. 2014 Apr 1;189(7):863-5. doi: 10.1164/rccm.201312-2260LE. No abstract available.

49.

Pulmonary 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertension.

Ruiter G, Wong YY, Raijmakers P, Huisman MC, Lammertsma AA, Knaapen P, de Man FS, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A.

Pulm Circ. 2013 Sep;3(3):647-53. doi: 10.1086/674335. Epub 2013 Nov 18.

50.

Pressure-overload-induced right heart failure.

Rain S, Handoko ML, Vonk Noordegraaf A, Bogaard HJ, van der Velden J, de Man FS.

Pflugers Arch. 2014 Jun;466(6):1055-63. doi: 10.1007/s00424-014-1450-1. Epub 2014 Feb 1. Review.

PMID:
24488007

Supplemental Content

Loading ...
Support Center